Zonova is a UK-based antimicrobial materials company developing embedded antimicrobial technologies for medical devices. Founded in 2023, the company’s proprietary platform integrates antimicrobial protection directly into polymers to prevent microbial colonisation and biofilm formation without relying on antibiotics or toxic leaching compounds. Zonova partners with medical device manufacturers through a scalable licensing model designed to accelerate infection-resistant innovation across global healthcare systems.
Zonova
- Health
- London, United Kingdom
- £2.1m
- zonovatech.com
- Update Information
More venture news
- 16 Jul 2026

BeCertainBeCertain raises a £1.7m pre-seed round led by Sure Valley Ventures for AI software that helps dentists interpret X-rays
Pre-seedHealth - 9 Jul 2026

Leo Cancer CareLeo Cancer Care unlock £50m Series D led by Yu Galaxy for its upright imaging and radiotherapy platform
Series DHealth - 8 Jul 2026

Respiro DiagnosticsRespiro Diagnostics raises a £1m pre-seed round led by Zinc Venture Capital and SFC Capital to develop breath-based liquid biopsy for lung cancer
Pre-seedHealth
